These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 21328688

  • 1. Regarding changing outcomes and treatment strategies for wire-induced coronary perforations in the era of bivalirudin use. A word of caution concerning the use of bivalirudin during coronary intervention for lesions at high risk for perforation.
    Movahed MR.
    Catheter Cardiovasc Interv; 2011 Feb 15; 77(3):456; author reply 457-8. PubMed ID: 21328688
    [No Abstract] [Full Text] [Related]

  • 2. Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.
    Kini AS, Rafael OC, Sarkar K, Rajdev S, Jakkula M, Mares AM, Kaplish D, Krishnan P, Kim MC, Sharma SK.
    Catheter Cardiovasc Interv; 2009 Nov 01; 74(5):700-7. PubMed ID: 19496119
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Failed pericardiocentesis for acute cardiac tamponade: two cases associated with bivalirudin administration during PCI.
    Al Shammeri OM, Crowell R, Stewart K, Fort S.
    Catheter Cardiovasc Interv; 2010 Jan 01; 75(1):114-6. PubMed ID: 19626695
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary intervention.
    Iijima R, Ndrepepa G, Mehilli J, Byrne RA, Schulz S, Neumann FJ, Richardt G, Berger PB, Schömig A, Kastrati A.
    Eur Heart J; 2009 Feb 01; 30(3):290-6. PubMed ID: 19147609
    [Abstract] [Full Text] [Related]

  • 7. Impact of bivalirudin on in-hospital bleeding and six-month outcomes in octogenarians undergoing percutaneous coronary intervention.
    Lemesle G, De Labriolle A, Bonello L, Syed A, Collins S, Maluenda G, Torguson R, Kaneshige K, Xue Z, Suddath WO, Satler LF, Kent KM, Lindsay J, Pichard AD, Waksman R.
    Catheter Cardiovasc Interv; 2009 Sep 01; 74(3):428-35. PubMed ID: 19360860
    [Abstract] [Full Text] [Related]

  • 8. Outcomes of coronary arterial perforations during percutaneous coronary intervention with bivalirudin anticoagulation.
    Romaguera R, Sardi G, Laynez-Carnicero A, Ben-Dor I, Maluenda G, Wakabayashi K, Hauville C, Torguson R, Xue Z, Kent KM, Satler LF, Suddath WO, Pichard AD, Lindsay J, Waksman R.
    Am J Cardiol; 2011 Oct 01; 108(7):932-5. PubMed ID: 21784388
    [Abstract] [Full Text] [Related]

  • 9. Oldies but goodies.
    Butman SM.
    Catheter Cardiovasc Interv; 2009 Sep 01; 74(3):436-7. PubMed ID: 19681122
    [No Abstract] [Full Text] [Related]

  • 10. Effect of bivalirudin compared with unfractionated heparin plus abciximab on infarct size and myocardial recovery after primary percutaneous coronary intervention: the horizons-AMI CMRI substudy.
    Wöhrle J, Merkle N, Kunze M, Cristea E, Mehran R, Rottbauer W, Stone GW.
    Catheter Cardiovasc Interv; 2012 Jun 01; 79(7):1083-9. PubMed ID: 22162175
    [Abstract] [Full Text] [Related]

  • 11. Influence of timing of clopidogrel treatment on the efficacy and safety of bivalirudin in patients with non-ST-segment elevation acute coronary syndromes undergoing percutaneous coronary intervention: an analysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
    Lincoff AM, Steinhubl SR, Manoukian SV, Chew D, Pollack CV, Feit F, Ware JH, Bertrand ME, Ohman EM, Desmet W, Cox DA, Mehran R, Stone GW, Acute Catheterization and Urgent Intervention Triage strategY of Trial Investigators.
    JACC Cardiovasc Interv; 2008 Dec 01; 1(6):639-48. PubMed ID: 19463378
    [Abstract] [Full Text] [Related]

  • 12. Clinical applications of bivalirudin in the cardiac catheterization laboratory.
    Thompson KA, Philip KJ, Schwarz ER.
    J Cardiovasc Pharmacol Ther; 2011 Jun 01; 16(2):140-9. PubMed ID: 21097669
    [Abstract] [Full Text] [Related]

  • 13. Closure of guide wire-induced coronary artery perforation with a two-component fibrin glue.
    Störger H, Ruef J.
    Catheter Cardiovasc Interv; 2007 Aug 01; 70(2):237-40. PubMed ID: 17420994
    [Abstract] [Full Text] [Related]

  • 14. Safety and efficacy of a prolonged bivalirudin infusion after urgent and complex percutaneous coronary interventions: a descriptive study.
    Cortese B, Micheli A, Picchi A, Bandinelli L, Brizi MG, Severi S, Limbruno U.
    Coron Artery Dis; 2009 Aug 01; 20(5):348-53. PubMed ID: 19543084
    [Abstract] [Full Text] [Related]

  • 15. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndrome initially treated with fondaparinux: results from an international, multicenter, randomized pilot study (SWITCH III).
    Waksman R, Bertrand O, Driesman M, Gruberg L, Rossi J, Mehta S, Swymelar S, Dvir D, Xue Z, Torguson R.
    J Interv Cardiol; 2013 Apr 01; 26(2):107-13. PubMed ID: 23240743
    [Abstract] [Full Text] [Related]

  • 16. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention.
    Watson K, Seybert AL, Saul MI, Lee JS, Kane-Gill SL.
    Pharmacotherapy; 2007 May 01; 27(5):647-56. PubMed ID: 17461699
    [Abstract] [Full Text] [Related]

  • 17. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
    Gurm HS, Smith DE, Chetcuti SJ, Share D, Khanal S, Riba A, Carter AJ, Lalonde T, Kline-Rogers E, O'Donnell M, O'Neill W, Safian R, Moscucci M, Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2).
    J Interv Cardiol; 2007 Jun 01; 20(3):197-203. PubMed ID: 17524111
    [Abstract] [Full Text] [Related]

  • 18. A randomized two-by-two comparison of high-dose bolus tirofiban versus abciximab and unfractionated heparin versus bivalirudin during percutaneous coronary revascularization and stent placement: the tirofiban evaluation of novel dosing versus abciximab with clopidogrel and inhibition of thrombin (TENACITY) study trial.
    Moliterno DJ, TENACITY Steering Committee and Investigators.
    Catheter Cardiovasc Interv; 2011 Jun 01; 77(7):1001-9. PubMed ID: 21598351
    [Abstract] [Full Text] [Related]

  • 19. Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.
    Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW, HORIZONS-AMI Trial Investigators.
    Lancet; 2009 Oct 03; 374(9696):1149-59. PubMed ID: 19717185
    [Abstract] [Full Text] [Related]

  • 20. Outcomes of Patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials. Heparin only should be considered for lesions at high risk for perforation.
    Movahed MR.
    J Interv Cardiol; 2010 Apr 03; 23(2):203. PubMed ID: 20236210
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.